Clinical Research Directory
Browse clinical research sites, groups, and studies.
Understanding RSV: Severe Disease and the Long Term Consequences
Sponsor: University of Oxford
Summary
The study design is a case-control, sample based study. 275 cases (Group 1), infants \<12 months old with RSV infection and 40 controls (Group 2), otherwise healthy infants \<12 months old without RSV infection will be recruited. Samples will be taken on enrolment and for infants in Group 1; repeated at 7 weeks convalescence. There will be annual follow up by questionnaire for up to 6 years and a minimum of 1 year, depending at what stage in the study the infant is enrolled.
Official title: REspiratory Syncytial Virus Consortium in EUrope (RESCEU):Presumed Risk Factors and Biomarkers for RSV-related Severe Disease and Related Sequelae
Key Details
Gender
All
Age Range
Any - 12 Months
Study Type
OBSERVATIONAL
Enrollment
315
Start Date
2017-12-19
Completion Date
2026-11
Last Updated
2022-11-22
Healthy Volunteers
Yes
Conditions
Interventions
RSV point of care testing
Patients will have 2 nasopharyngeal swabs, a nasal swab, a stool and urine taken at baseline/ enrolment and the RSV positive ARTI group will have samples repeated at 6-8weeks.
Locations (2)
Oxford University Hospitals NHS Trust
Oxford, United Kingdom
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine
Oxford, United Kingdom